{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:41:20Z","timestamp":1793468480088,"version":"4.5.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,15]],"date-time":"2027-09-15T00:00:00Z","timestamp":1820966400000},"content-version":"am","delay-in-days":349,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["NIH\/NCI R01 CA206180"],"award-info":[{"award-number":["NIH\/NCI R01 CA206180"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jhep.2026.04.017","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T19:56:19Z","timestamp":1784577379000},"page":"712-726","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial intelligence and personalised medicine in liver cancer"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3330-8227","authenticated-orcid":false,"given":"Nickolai Joel","family":"Matuschewski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5266-4181","authenticated-orcid":false,"given":"William","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Calderaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib1","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib2","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"10360","key":"10.1016\/j.jhep.2026.04.017_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jhep.2026.04.017_bib4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2025.10.020","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: The 2025 update","volume":"84","author":"Reig","year":"2026","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma","volume":"82","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib7","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib8","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamaoncol.2023.2677","article-title":"Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma: A Review","volume":"10","author":"Cappuyns","year":"2024","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/hep.30811","article-title":"Clinical Impact of Genomic Diversity From Early to Advanced Hepatocellular Carcinoma","volume":"71","author":"Nault","year":"2020","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.jhep.2026.04.017_bib10","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1158\/0008-5472.CAN-09-1089","article-title":"Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma","volume":"69","author":"Hoshida","year":"2009","journal-title":"Cancer Res"},{"issue":"17","key":"10.1016\/j.jhep.2026.04.017_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15174221","article-title":"Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma","volume":"15","author":"Gorji","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.jhep.2026.04.017_bib12","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular Carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1470-2045(18)30937-9","article-title":"Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased \u03b1-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Zhu","year":"2019","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.017_bib14","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/s41591-022-01868-2","article-title":"Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma","volume":"28","author":"Zhu","year":"2022","journal-title":"Nat Med"},{"issue":"15","key":"10.1016\/j.jhep.2026.04.017_bib15","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1200\/JCO.23.02745","article-title":"Systemic therapy for advanced hepatocellular carcinoma: ASCO guideline update","volume":"42","author":"Gordan","year":"2024","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jamasurg.2022.5697","article-title":"Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma","volume":"158","author":"Di Benedetto","year":"2023","journal-title":"JAMA Surg"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/SLA.0000000000006386","article-title":"Tumor Mutational Burden From Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection: An Emerging Biomarker for Surveillance","volume":"280","author":"Wehrle","year":"2024","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib18","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1097\/SLA.0000000000005380","article-title":"A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular Carcinoma","volume":"277","author":"Zhu","year":"2023","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib19","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.jhep.2023.08.020","article-title":"AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation","volume":"79","author":"Norman","year":"2023","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2026.04.017_bib20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/SLA.0000000000005637","article-title":"A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation","volume":"276","author":"Pinto-Marques","year":"2022","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.jhep.2026.04.017_bib21","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/gutjnl-2019-320282","article-title":"Liquid biopsy in the clinical management of hepatocellular carcinoma","volume":"69","author":"von Felden","year":"2020","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prro.2021.09.004","article-title":"External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline","volume":"12","author":"Apisarnthanarax","year":"2022","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1200\/JCO.22.00392","article-title":"Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)","volume":"41","author":"Peng","year":"2023","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.017_bib25","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/gutjnl-2019-318934","article-title":"Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial","volume":"69","author":"Kudo","year":"2020","journal-title":"Gut"},{"issue":"3_suppl","key":"10.1016\/j.jhep.2026.04.017_bib26","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.3_suppl.LBA432","article-title":"EMERALD-1: A phase 3, randomized, placebo-controlled study of transarterial chemoembolization combined with durvalumab with or without bevacizumab in participants with unresectable hepatocellular carcinoma eligible for embolization","volume":"42","author":"Lencioni","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"10474","key":"10.1016\/j.jhep.2026.04.017_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(24)02575-3","article-title":"Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study","volume":"405","author":"Kudo","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.017_bib28","doi-asserted-by":"crossref","DOI":"10.1162\/neco.1989.1.4.541","article-title":"Backpropagation Applied to Handwritten Zip Code Recognition","volume":"1","author":"LeCun","year":"1989","journal-title":"Neural Computation"},{"key":"10.1016\/j.jhep.2026.04.017_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2023.103000","article-title":"Advances in medical image analysis with vision Transformers: A comprehensive review","volume":"91","author":"Azad","year":"2024","journal-title":"Med Image Anal"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib30","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.242961","article-title":"Generative AI and Foundation Models in Radiology: Applications, Opportunities, and Potential Challenges","volume":"317","author":"Tavakoli","year":"2025","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2026.04.017_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2025.103621","article-title":"Navigating the landscape of multimodal AI in medicine: A scoping review on technical challenges and clinical applications","volume":"105","author":"Schouten","year":"2025","journal-title":"Med Image Anal"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib32","article-title":"Evaluating the efficacy of using large language models in preoperative prediction of microvascular invasion in HCC: a multicenter study","volume":"15","author":"Ding","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib33","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s00261-025-05127-z","article-title":"Natural language processing and LLMs in liver imaging: a practical review of clinical applications","volume":"51","author":"L\u00f3pez-\u00dabeda","year":"2026","journal-title":"Abdom Radiol (NY)"},{"issue":"5","key":"10.1016\/j.jhep.2026.04.017_bib34","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/S1470-2045(19)30154-8","article-title":"Digital pathology and artificial intelligence","volume":"20","author":"Niazi","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41377-023-01104-7","article-title":"Deep learning-enabled virtual histological staining of biological samples","volume":"12","author":"Bai","year":"2023","journal-title":"Light Sci Appl"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib36","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.240982","article-title":"Navigating the AI Landscape in Medical Imaging: A Critical Analysis of Technologies, Implementation, and Implications","volume":"315","author":"Sosna","year":"2025","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.jhep.2026.04.017_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/M13-1133","article-title":"Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010","volume":"160","author":"Denniston","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-67013-6","article-title":"Finding undiagnosed patients with hepatitis C infection: an application of artificial intelligence to patient claims data","volume":"10","author":"Doyle","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib39","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1038\/s41598-023-30440-2","article-title":"The development of a machine learning algorithm for early detection of viral hepatitis B infection in Nigerian patients","volume":"13","author":"Ajuwon","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2026.04.017_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2023.105243","article-title":"Machine learning for prediction of viral hepatitis: A systematic review and meta-analysis","volume":"179","author":"Moulaei","year":"2023","journal-title":"Int J Med Inform"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib41","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.017_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib43","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jhep.2020.07.025","article-title":"aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis","volume":"73","author":"Fan","year":"2020","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.017_bib44","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jhep.2023.05.039","article-title":"Novel, high accuracy models for hepatocellular carcinoma prediction based on longitudinal data and cell-free DNA signatures","volume":"79","author":"Fan","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jhep.2021.09.025","article-title":"An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B","volume":"76","author":"Kim","year":"2022","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2026.04.017_bib46","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/liv.16050","article-title":"AI-powered prediction of HCC recurrence after surgical resection: Personalised intervention opportunities using patient-specific risk factors","volume":"44","author":"Zandavi","year":"2024","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib47","doi-asserted-by":"crossref","first-page":"7730","DOI":"10.1038\/s41598-025-91728-z","article-title":"Deep learning for hepatocellular carcinoma recurrence before and after liver transplantation: a multicenter cohort study","volume":"15","author":"Cao","year":"2025","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12880-025-01751-9","article-title":"MRI radiomics model for predicting tumor immune microenvironment types and efficacy of anti-PD-1\/PD-L1 therapy in hepatocellular carcinoma","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Med Imaging"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib49","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1186\/s12885-025-14247-0","article-title":"Prediction of prognosis of immune checkpoint inhibitors combined with anti-angiogenic agents for unresectable hepatocellular carcinoma by machine learning-based radiomics","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib50","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/jmri.26839","article-title":"User and system pitfalls in liver imaging with LI-RADS","volume":"50","author":"Elsayes","year":"2019","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071673","article-title":"Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications","volume":"13","author":"Vitale","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.017_bib52","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1007\/s00261-021-03100-0","article-title":"Imaging of treatment response during systemic therapy for hepatocellular carcinoma","volume":"46","author":"Masch","year":"2021","journal-title":"Abdom Radiol (NY)"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.017_bib53","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2021.07.004","article-title":"Systemic treatment of hepatocellular carcinoma: An EASL position paper","volume":"75","author":"Bruix","year":"2021","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib54","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.243819","article-title":"The Current Status of AI-accelerated MRI Techniques in Clinical Use","volume":"317","author":"Haller","year":"2025","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib55","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220133","article-title":"Clinical Impact of Deep Learning Reconstruction in MRI","volume":"43","author":"Kiryu","year":"2023","journal-title":"Radiographics"},{"key":"10.1016\/j.jhep.2026.04.017_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2025.105903","article-title":"A systematic review of generative AI approaches for medical image enhancement: Comparing GANs, transformers, and diffusion models","volume":"199","author":"Oulmalme","year":"2025","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.jhep.2026.04.017_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.109717","article-title":"Artificial intelligence in ultrasound","volume":"139","author":"Shen","year":"2021","journal-title":"Eur J Radiol"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib58","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1109\/TMI.2018.2820120","article-title":"Compressed Sensing MRI Reconstruction Using a Generative Adversarial Network With a Cyclic Loss","volume":"37","author":"Quan","year":"2018","journal-title":"IEEE Trans Med Imaging"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.017_bib59","doi-asserted-by":"crossref","first-page":"e1001624","DOI":"10.1371\/journal.pmed.1001624","article-title":"Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis","volume":"11","author":"Singal","year":"2014","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.jhep.2026.04.017_bib60","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s10916-017-0797-1","article-title":"Extreme Learning Machine Framework for Risk Stratification of Fatty Liver Disease Using Ultrasound Tissue Characterization","volume":"41","author":"Kuppili","year":"2017","journal-title":"J Med Syst"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jum.15693","article-title":"Liver Fat Assessment in Multiview Sonography Using Transfer Learning With Convolutional Neural Networks","volume":"41","author":"Byra","year":"2022","journal-title":"J Ultrasound Med"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib62","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1148\/radiol.2020191160","article-title":"Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat with Radiofrequency Ultrasound Data Using One-dimensional Convolutional Neural Networks","volume":"295","author":"Han","year":"2020","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.jhep.2026.04.017_bib63","doi-asserted-by":"crossref","DOI":"10.2196\/30066","article-title":"Deep Learning Techniques for Fatty Liver Using Multi-View Ultrasound Images Scanned by Different Scanners: Development and Validation Study","volume":"9","author":"Kim","year":"2021","journal-title":"JMIR Med Inform"},{"key":"10.1016\/j.jhep.2026.04.017_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1472-6947-12-55","article-title":"Artificial neural network aided non-invasive grading evaluation of hepatic fibrosis by duplex ultrasonography","volume":"12","author":"Zhang","year":"2012","journal-title":"BMC Med Inform Decis Mak"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib65","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1148\/radiol.2018180763","article-title":"Development and Validation of a Deep Learning System for Staging Liver Fibrosis by Using Contrast Agent-enhanced CT Images in the Liver","volume":"289","author":"Choi","year":"2018","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1148\/radiol.2017171928","article-title":"Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid-enhanced Hepatobiliary Phase MR Images","volume":"287","author":"Yasaka","year":"2018","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib67","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jhep.2024.12.029","article-title":"AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B","volume":"82","author":"Shin","year":"2025","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib68","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jhep.2020.05.052","article-title":"Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status","volume":"73","author":"Audureau","year":"2020","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib69","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1007\/s00330-019-06205-9","article-title":"Deep learning for liver tumor diagnosis part I: development of a convolutional neural network classifier for multi-phasic MRI","volume":"29","author":"Hamm","year":"2019","journal-title":"European Radiology"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib70","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1007\/s00330-020-07559-1","article-title":"Deep learning\u2013assisted differentiation of pathologically proven atypical and typical hepatocellular carcinoma (HCC) versus non-HCC on contrast-enhanced MRI of the liver","volume":"31","author":"Oestmann","year":"2021","journal-title":"European Radiology"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib71","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1148\/radiol.2017170706","article-title":"Deep Learning with Convolutional Neural Network for Differentiation of Liver Masses at Dynamic Contrast-enhanced CT: A Preliminary Study","volume":"286","author":"Yasaka","year":"2018","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib72","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s41467-024-45325-9","article-title":"A multicenter clinical AI system study for detection and diagnosis of focal liver lesions","volume":"15","author":"Ying","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2026.04.017_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102777","article-title":"Improving B-mode ultrasound diagnostic performance for focal liver lesions using deep learning: A multicentre study","volume":"56","author":"Yang","year":"2020","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib74","doi-asserted-by":"crossref","first-page":"7749","DOI":"10.1038\/s41598-022-11506-z","article-title":"The feasibility to use artificial intelligence to aid detecting focal liver lesions in real-time ultrasound: a preliminary study based on videos","volume":"12","author":"Tiyarattanachai","year":"2022","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib75","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jhep.2025.01.011","article-title":"Contrast-enhanced ultrasound-based AI model for multi-classification of focal liver lesions","volume":"83","author":"Ding","year":"2025","journal-title":"Journal of Hepatology"},{"issue":"10","key":"10.1016\/j.jhep.2026.04.017_bib76","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1109\/JBHI.2020.2977937","article-title":"Differential Diagnosis of Atypical Hepatocellular Carcinoma in Contrast-Enhanced Ultrasound Using Spatio-Temporal Diagnostic Semantics","volume":"24","author":"Huang","year":"2020","journal-title":"IEEE J Biomed Health Inform"},{"key":"10.1016\/j.jhep.2026.04.017_bib77","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3389\/fonc.2020.00680","article-title":"Deep learning for accurate diagnosis of liver tumor based on magnetic resonance imaging and clinical data","volume":"10","author":"Zhen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhep.2026.04.017_bib78","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ejmp.2021.02.013","article-title":"A deep survival interpretable radiomics model of hepatocellular carcinoma patients","volume":"82","author":"Wei","year":"2021","journal-title":"Phys Med"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib79","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1007\/s00330-019-06214-8","article-title":"Deep learning for liver tumor diagnosis part II: convolutional neural network interpretation using radiologic imaging features","volume":"29","author":"Wang","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib80","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.240332","article-title":"Interactive explainable deep learning model for hepatocellular carcinoma diagnosis at gadoxetic acid-enhanced MRI: a retrospective, multicenter, diagnostic study","volume":"7","author":"Li","year":"2025","journal-title":"Radiol Imaging Cancer"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib81","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation Barcelona Clinic Liver Cancer (BCLC) staging system. The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.jhep.2026.04.017_bib82","doi-asserted-by":"crossref","first-page":"6940","DOI":"10.1007\/s00330-024-10624-8","article-title":"Automated graded prognostic assessment for patients with hepatocellular carcinoma using machine learning","volume":"34","author":"Gross","year":"2024","journal-title":"European Radiology"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib83","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.surg.2006.06.028","article-title":"Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes","volume":"141","author":"Shah","year":"2007","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib84","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jhep.2009.12.037","article-title":"Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study","volume":"52","author":"Cucchetti","year":"2010","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5152\/dir.2018.17467","article-title":"A radiomics nomogram for preoperative prediction of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma","volume":"24","author":"Peng","year":"2018","journal-title":"Diagn Interv Radiol"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib86","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1007\/s00330-018-5985-y","article-title":"Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT","volume":"29","author":"Ma","year":"2019","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib87","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","article-title":"Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma","volume":"70","author":"Xu","year":"2019","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.jhep.2026.04.017_bib88","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.hpb.2023.01.015","article-title":"The utility of Vision Transformer in preoperatively predicting microvascular invasion status of hepatocellular carcinoma","volume":"25","author":"Xu","year":"2023","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.jhep.2026.04.017_bib89","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00432-020-03366-9","article-title":"Preoperative identification of microvascular invasion in hepatocellular carcinoma by XGBoost and deep learning","volume":"147","author":"Jiang","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jhep.2026.04.017_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111348","article-title":"Prediction of microvascular invasion and pathological differentiation of hepatocellular carcinoma based on a deep learning model","volume":"172","author":"He","year":"2024","journal-title":"Eur J Radiol"},{"issue":"12","key":"10.1016\/j.jhep.2026.04.017_bib91","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1007\/s00432-021-03617-3","article-title":"Using deep learning to predict microvascular invasion in hepatocellular carcinoma based on dynamic contrast-enhanced MRI combined with clinical parameters","volume":"147","author":"Song","year":"2021","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.jhep.2026.04.017_bib92","article-title":"Prediction of microvascular invasion of hepatocellular carcinoma based on contrast-enhanced MR and 3D convolutional neural networks","volume":"11","author":"Zhou","year":"2021","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib93","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/HEP.0000000000001180","article-title":"Multimodal multiphasic preoperative image-based deep-learning predicts HCC outcomes after curative surgery","volume":"82","author":"Hui","year":"2025","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jhep.2026.04.017_bib94","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1007\/s00330-024-11173-w","article-title":"Predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma: nomograms based on deep learning analysis of gadoxetic acid-enhanced MRI","volume":"35","author":"Jeong","year":"2025","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.jhep.2026.04.017_bib95","doi-asserted-by":"crossref","DOI":"10.1148\/ryai.230601","article-title":"Deep learning segmentation of ascites on abdominal CT scans for automatic volume quantification","volume":"6","author":"Hou","year":"2024","journal-title":"Radiol Artif Intell"},{"issue":"13","key":"10.1016\/j.jhep.2026.04.017_bib96","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.cgh.2020.03.034","article-title":"Deep convolutional neural network-aided detection of portal hypertension in patients with cirrhosis","volume":"18","author":"Liu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.04.017_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.853254","article-title":"Development and validation of a pyradiomics signature to predict initial treatment response and prognosis during transarterial chemoembolization in hepatocellular carcinoma","volume":"12","author":"Peng","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jhep.2026.04.017_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112353","article-title":"Development and validation of interpretable machine learning model for pre-treatment predicting the response to targeted and immune therapy in hepatocellular carcinoma","volume":"191","author":"Huang","year":"2025","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.017_bib99","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2025.04.017","article-title":"Machine learning based radiomic models outperform clinical biomarkers in predicting outcomes after immunotherapy for hepatocellular carcinoma","volume":"83","author":"Vithayathil","year":"2025","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.jhep.2026.04.017_bib100","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1016\/j.acra.2025.07.008","article-title":"Radiomics-based Machine Learning for Predicting Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: a Systematic Review and Meta-analysis","volume":"32","author":"Liang","year":"2025","journal-title":"Acad Radiol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00330-024-10955-6","article-title":"Tumor response assessment in hepatocellular carcinoma treated with immunotherapy: imaging biomarkers for clinical decision-making","volume":"35","author":"Sobirey","year":"2024","journal-title":"European Radiology"},{"issue":"10","key":"10.1016\/j.jhep.2026.04.017_bib102","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1007\/s00330-021-07891-0","article-title":"Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI","volume":"31","author":"Rong","year":"2021","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib103","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.221291","article-title":"CT radiomics to predict macrotrabecular-massive subtype and immune status in hepatocellular carcinoma","volume":"307","author":"Feng","year":"2023","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib104","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.242750","article-title":"Noninvasive Tumor Profiling: Quantitative Contrast-Enhanced MRI Markers Predict PD-L1 and CTNNB1 Status in Hepatocellular Carcinoma","volume":"316","author":"Matuschewski","year":"2025","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib105","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1007\/s00330-020-06675-2","article-title":"MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma","volume":"30","author":"Hectors","year":"2020","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib106","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00262-021-02957-w","article-title":"Imaging features of gadoxetic acid-enhanced MR imaging for evaluation of tumor-infiltrating CD8 cells and PD-L1 expression in hepatocellular carcinoma","volume":"71","author":"Sun","year":"2022","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib107","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.jhep.2020.07.026","article-title":"Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma","volume":"73","author":"Sangro","year":"2020","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib108","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1158\/1078-0432.CCR-18-2293","article-title":"Prospective genotyping of hepatocellular carcinoma: clinical implications of next-generation sequencing for matching patients to targeted and immune therapies","volume":"25","author":"Harding","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2026.04.017_bib109","article-title":"The use of artificial intelligence in stereotactic ablative body radiotherapy for hepatocellular carcinoma","volume":"12","author":"Katano","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"23","key":"10.1016\/j.jhep.2026.04.017_bib110","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/abc12c","article-title":"Deep learning-based inverse mapping for fluence map prediction","volume":"65","author":"Ma","year":"2020","journal-title":"Phys Med Biol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib111","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s13014-022-02138-8","article-title":"Machine learning-based normal tissue complication probability model for predicting albumin-bilirubin (ALBI) grade increase in hepatocellular carcinoma patients","volume":"17","author":"Prayongrat","year":"2022","journal-title":"Radiat Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib112","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/HEP.0000000000001314","article-title":"Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"83","author":"Singh","year":"2026","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.04.017_bib113","doi-asserted-by":"crossref","DOI":"10.2196\/78306","article-title":"Diagnostic Performance of computed tomography-based artificial intelligence for early recurrence of cholangiocarcinoma: systematic review and meta-analysis","volume":"27","author":"Chen","year":"2025","journal-title":"J Med Internet Res"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib114","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2020-000910","article-title":"Machine learning: an approach to preoperatively predict PD-1\/PD-L1 expression and outcome in intrahepatic cholangiocarcinoma using MRI biomarkers","volume":"5","author":"Zhang","year":"2020","journal-title":"ESMO Open"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2020.0930","article-title":"A Phase 2 Multi-institutional Study of Nivolumab for patients with advanced refractory biliary tract cancer","volume":"6","author":"Kim","year":"2020","journal-title":"JAMA Oncol"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.017_bib116","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1053\/j.gastro.2020.06.021","article-title":"Clinical-grade detection of microsatellite instability in colorectal tumors by deep learning","volume":"159","author":"Echle","year":"2020","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib117","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/s41591-019-0462-y","article-title":"Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer","volume":"25","author":"Kather","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib118","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(20)30535-0","article-title":"Deep learning model for the prediction of microsatellite instability in colorectal cancer: a diagnostic study","volume":"22","author":"Yamashita","year":"2021","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.jhep.2026.04.017_bib119","article-title":"Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide images","volume":"3","author":"Lazard","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jhep.2026.04.017_bib120","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41523-018-0079-1","article-title":"Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype","volume":"4","author":"Couture","year":"2018","journal-title":"NPJ Breast Cancer"},{"issue":"7","key":"10.1016\/j.jhep.2026.04.017_bib121","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.7700","article-title":"Artificial intelligence algorithms to assess hormonal status from tissue microarrays in patients with breast cancer","volume":"2","author":"Shamai","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.jhep.2026.04.017_bib122","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1038\/s41379-022-01141-4","article-title":"Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms","volume":"35","author":"Mayer","year":"2022","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhep.2026.04.017_bib123","doi-asserted-by":"crossref","first-page":"e2200070","DOI":"10.1200\/CCI.22.00070","article-title":"Artificial intelligence-powered prediction of ALK gene rearrangement in patients with non-small-cell lung cancer","volume":"6","author":"Terada","year":"2022","journal-title":"JCO Clin Cancer Inform"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib124","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.jid.2021.09.034","article-title":"Deep learning and pathomics analyses reveal cell nuclei as important features for mutation prediction of BRAF-mutated melanomas","volume":"142","author":"Kim","year":"2022","journal-title":"J Invest Dermatol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib125","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12915-024-02022-9","article-title":"Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor types","volume":"22","author":"Loeffler","year":"2024","journal-title":"BMC Biol"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.017_bib126","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s43018-020-0087-6","article-title":"Pan-cancer image-based detection of clinically actionable genetic alterations","volume":"1","author":"Kather","year":"2020","journal-title":"Nat Cancer"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib127","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41698-024-00592-z","article-title":"Deep learning for dual detection of microsatellite instability and POLE mutations in colorectal cancer histopathology","volume":"8","author":"Gustav","year":"2024","journal-title":"NPJ Precis Oncol"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib128","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1002\/hep.31207","article-title":"Predicting survival after hepatocellular carcinoma resection using deep learning on histological slides","volume":"72","author":"Saillard","year":"2020","journal-title":"Hepatology"},{"issue":"8060","key":"10.1016\/j.jhep.2026.04.017_bib129","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/s41586-025-08668-x","article-title":"Spatial immune scoring system predicts hepatocellular carcinoma recurrence","volume":"640","author":"Jia","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.04.017_bib130","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1008585","article-title":"A confidence-based, artificial intelligence pathology model for diagnosis of intrahepatic cholangiocarcinoma","author":"Cheng","year":"2026","journal-title":"Ann Oncol"},{"issue":"12","key":"10.1016\/j.jhep.2026.04.017_bib131","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S1470-2045(23)00468-0","article-title":"Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study","volume":"24","author":"Zeng","year":"2023","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.jhep.2026.04.017_bib132","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/1078-0432.CCR-17-0853","article-title":"Deep learning-based multi-omics integration robustly predicts survival in liver cancer","volume":"24","author":"Chaudhary","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.jhep.2026.04.017_bib133","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ccell.2022.07.004","article-title":"Pan-cancer integrative histology-genomic analysis via multimodal deep learning","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"issue":"7873","key":"10.1016\/j.jhep.2026.04.017_bib134","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.jhep.2026.04.017_bib135","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41401-023-01167-7","article-title":"Deep learning enables the discovery of a novel cuproptosis-inducing molecule for the inhibition of hepatocellular carcinoma","volume":"45","author":"Yang","year":"2024","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib136","article-title":"Kinic index: an artificial intelligence-driven predictive model and multitarget drug discovery framework for hepatocellular carcinoma patients","volume":"10","author":"Zhou","year":"2026","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.jhep.2026.04.017_bib137","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41698-025-00952-3","article-title":"Integrating single-cell RNA sequencing and artificial intelligence for multitargeted drug design for combating resistance in liver cancer","volume":"9","author":"Wang","year":"2025","journal-title":"NPJ Precis Oncol"},{"issue":"22","key":"10.1016\/j.jhep.2026.04.017_bib138","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1158\/0008-5472.CAN-21-0955","article-title":"Computational analysis of cholangiocarcinoma phosphoproteomes identifies patient-specific drug targets","volume":"81","author":"Khorsandi","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2026.04.017_bib139","article-title":"Multiomics combined with machine learning defines unique molecular subtypes of cholangiocarcinoma and identifies TNK1 as a therapeutic target","author":"Mun","year":"2025","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.jhep.2026.04.017_bib140","doi-asserted-by":"crossref","DOI":"10.1111\/liv.16051","article-title":"ViT-based quantification of intratumoral heterogeneity for predicting the early recurrence in HCC following multiple ablation","volume":"45","author":"Zhang","year":"2025","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.jhep.2026.04.017_bib141","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1007\/s00261-024-04501-7","article-title":"Large language models' responses to liver cancer surveillance, diagnosis, and management questions: accuracy, reliability, readability","volume":"49","author":"Cao","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.jhep.2026.04.017_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2025.115408","article-title":"Effect of a ChatGPT-based digital counseling intervention on anxiety and depression in patients with cancer: a prospective, randomized trial","volume":"221","author":"Akdogan","year":"2025","journal-title":"Eur J Cancer"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826002205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T16:55:33Z","timestamp":1789491333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826002205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0168827826002205"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.017","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial intelligence and personalised medicine in liver cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}